
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
-->
Many events look like seizures, but are not. Sometimes the diagnosis of seizure cannot be made until a child has experienced a few events






